MDT · Medtronic plc · Executive Compensation

$86.15 -0.14 (-0.16%)

S&P 500 member Russell 1000 member Rebalance outlook locked

Market Cap

$113.38B

1.28B

Volume · Sep 30 26.62M Avg daily vol (3M) 8.78M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2026

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Geoff Martha	Chairman and Chief Executive Officer	$1,399,039	—	$13,672,200	$5,175,559	$2,307,200	$386,255	$22,940,252
Thierry Pieton	EVP, Chief Financial Officer	$849,648	$2,000,000	$3,170,470	$1,200,139	$963,050	$404,079	$8,587,387
Brett Wall	Former EVP & President, Neuroscience Portfolio	$799,519	—	$3,566,703	$1,350,152	$824,000	$381,050	$6,921,425
Mike Marinaro	EVP & President Medical Surgical Portfolio & Americas	$819,616	—	$3,566,703	$1,350,152	$971,290	$125,075	$6,832,836
Michelle Quinn	EVP, General Counsel and Secretary	$600,000	$1,100,000	$3,481,600	$750,082	$617,423	$170,065	$6,719,170

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Geoff Martha	Chairman and Chief Executive Officer	$1,350,000	—	$12,625,000	$4,800,365	$1,883,250	$581,443	$21,240,058
Geoffrey S. Martha	Chairman and Chief Executive Officer	$1,350,000	—	$12,625,000	$4,800,365	$1,883,250	$581,443	$21,240,058
Sean M. Salmon	Former EVP & President, Cardiovascular Portfolio	$884,654	—	$4,537,157	$1,725,131	$823,050	$43,719	$8,396,597
Brett A. Wall	EVP & President, Neuroscience Portfolio	$774,519	—	$4,537,157	$1,725,131	$720,750	$363,656	$8,121,213
Brett Wall	Former EVP & President, Neuroscience Portfolio	$774,519	—	$4,537,157	$1,725,131	$720,750	$363,656	$8,121,213
Gregory L. Smith	EVP Enterprise Operations	$894,560	—	$4,537,157	$1,725,131	$832,350	$94,784	$8,083,981
Thierry Pieton	Executive Vice President and Chief Financial Officer	$138,517	—	$4,190,625	$600,056	$141,975	$141,274	$5,212,448
Gary L. Corona	Former SVP Corporate Finance (former Interim CFO)	$466,346	—	$3,089,088	$25,002	—	$214,812	$3,795,248
Karen Parkhill	Former Executive Vice President and Chief Financial Officer	$262,856	—	—	—	—	$7,823	$270,679

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Geoffrey S. Martha	Chairman and Chief Executive Officer	$1,350,000	—	$12,023,903	$4,499,959	$1,905,272	$305,496	$20,084,630
Geoff Martha	Chairman and Chief Executive Officer	$1,350,000	—	$12,023,903	$4,499,959	$1,905,272	$305,496	$20,084,630
Robert J. White	Former EVP & President, Medical Surgical Portfolio	$794,539	—	$3,206,416	$1,200,003	$794,539	$3,318,756	$9,314,253
Karen Parkhill	Former Executive Vice President and Chief Financial Officer	$911,233	—	$4,408,840	$1,649,997	$943,091	$66,187	$7,979,348
Gregory L. Smith	EVP Enterprise Operations	$872,100	—	$4,706,498	$1,200,003	$820,537	$65,018	$7,664,156
Sean M. Salmon	Former EVP & President, Cardiovascular Portfolio	$867,000	—	$3,406,800	$1,274,992	$774,952	$39,684	$6,548,787
Brett A. Wall	EVP & President, Neuroscience Portfolio	$749,358	—	$3,406,800	$1,274,992	$670,610	$334,272	$6,436,032
Brett Wall	Former EVP & President, Neuroscience Portfolio	$749,358	—	$3,406,800	$1,274,992	$670,610	$334,272	$6,436,032

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Geoffrey S. Martha	Chairman and Chief Executive Officer	$1,350,000	—	$9,626,040	$3,975,004	—	$443,588	$15,394,633
Karen Parkhill	Former Executive Vice President and Chief Financial Officer	$911,059	—	$3,632,502	$1,500,017	—	$81,181	$6,124,759
Sean M. Salmon	Former EVP & President, Cardiovascular Portfolio	$867,000	—	$2,905,963	$1,200,013	—	$33,968	$5,364,646
Rob ten Hoedt	EVP & President, Global Regions	$907,368	$269,630	$2,470,097	$1,020,004	—	$62,095	$5,047,748
Robert J. White	Former EVP & President, Medical Surgical Portfolio	$794,539	—	$2,905,963	$1,200,013	—	$130,681	$5,031,197

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Geoffrey S. Martha	Chairman and Chief Executive Officer	$1,345,192	—	$9,762,502	$3,750,293	$2,553,466	$450,497	$17,861,949
Karen Parkhill	Former Executive Vice President and Chief Financial Officer	$901,543	—	$3,670,802	$1,435,118	$1,420,581	$90,611	$7,518,655
Robert J. White	Former EVP & President, Medical Surgical Portfolio	$793,952	—	$3,123,977	$1,225,100	$1,094,944	$115,702	$6,353,675
Rob ten Hoedt	EVP & President, Global Regions	$881,294	—	$2,655,555	$1,045,098	$1,077,580	$62,120	$5,938,889

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Geoffrey S. Martha	Chairman and Chief Executive Officer	$1,142,308	—	$8,910,812	$4,504,950	$2,740,000	$209,257	$17,507,326
Karen Parkhill	Executive Vice President and Chief Financial Officer	$900,876	—	$3,485,130	$2,145,007	$2,322,211	$68,656	$8,921,879
Robert J. White	EVP & President, Medical Surgical Portfolio	$793,364	—	$2,851,540	$1,745,006	$1,781,315	$82,952	$7,254,177

Executive changes

Person	Role	Change	Effective	Filed
Kweli Thompson	Executive Vice President and President, Neuroscience Portfolio	Appointed	2026-06-01	2026-05-18
Gregory L. Smith	Executive Vice President, Enterprise Operations	Retired	2025-12-02	2025-11-03
William Jellison	director	Appointed	2025-08-19	2025-08-19
John Groetelaars	director	Appointed	2025-08-19	2025-08-19
Dr. Joon Lee	director	Appointed	2025-06-18	2025-06-23
Skip Kiil	EVP and President, Cardiovascular Portfolio	Appointed	2025-05-21	2025-05-21
Sean Salmon	EVP and President, Cardiovascular Portfolio	Resigned	2025-05-21	2025-05-21
Denise L. Blomquist	Global Controller and Principal Accounting Officer	Appointed	2025-03-17	2025-03-17
Jennifer M. Kirk	Global Controller and Principal Accounting Officer	Resigned	2025-05-02	2025-03-17
Thierry Pieton	Executive Vice President and Chief Financial Officer	Appointed	2025-03-03	2025-01-21
Gary Corona	Interim Chief Financial Officer	Appointed	—	2024-06-26
Karen L. Parkhill	Executive Vice President and Chief Financial Officer	Resigned	2024-08-02	2024-06-26
Rob ten Hoedt	Executive Vice President and President, Global Regions	Retired	2024-06-28	2024-06-04
Robert J. White	Executive Vice President and President of Medtronic's Medical Surgical Portfolio	Terminated	2024-04-26	2024-02-20
Greg Lewis	director	Appointed	2023-06-26	2023-06-26

Key facts CIK 1613103 CUSIP G5960L103 13F (30d) 48 filings 28 filers Visit website Investor relations